Population-Based Analysis of Neoplastic Changes in Cystic Lesions of the Pancreas.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• The inclusion criteria for this study are intentionally broad. Eligible patients for prospective enrollment will include

• Adults ≥ 30 years of age

• Have a radiographic or endoscopic diagnosis of at least one pancreatic cysts regardless of treatment status,

• No history of pancreatic cancer,

• Can speak and read English,

• Have access to a computer or mobile device (\

⁃ 95% of U.S. population); and

• Are able to complete an electronic informed consent.

Locations
United States
California
University of California, San Francisco
RECRUITING
San Francisco
Contact Information
Primary
Charysa Santos, BS
Charysa.Santos@ucsf.edu
415-514-6914
Backup
Kimberly S Kirkwood, MD
kim.kirkwood@ucsf.edu
415-502-5577
Time Frame
Start Date: 2019-10-08
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 4000
Treatments
Retrospective
The registry will be populated with a retrospective cohort of patients previously identified as having pancreatic cysts.
Prospective
The prospectively enrolled patients in this study are the primary population of interest.
Related Therapeutic Areas
Sponsors
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov